vs
Orchestra BioMed Holdings, Inc.（OBIO）与Penumbra Inc（PEN）财务数据对比。点击上方公司名可切换其他公司
Penumbra Inc的季度营收约是Orchestra BioMed Holdings, Inc.的12.5倍（$385.4M vs $30.9M）。Orchestra BioMed Holdings, Inc.净利率更高（20.2% vs 12.3%，领先7.9%）。Orchestra BioMed Holdings, Inc.同比增速更快（12120.2% vs 22.1%）。Penumbra Inc自由现金流更多（$68.0M vs $-2.3M）。过去两年Orchestra BioMed Holdings, Inc.的营收复合增速更高（606.2% vs 17.6%）
Orchestra BioMed Holdings是一家临床阶段医疗科技企业，专注于开发针对心血管及其他高负担慢性疾病的新型循证治疗方案，核心业务覆盖介入心脏病学、慢病护理优化等领域，主要面向北美、欧洲市场运营，与头部医疗行业参与者开展合作。
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
OBIO vs PEN — 直观对比
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $30.9M | $385.4M |
| 净利润 | $6.2M | $47.3M |
| 毛利率 | 99.8% | 68.0% |
| 营业利润率 | 21.8% | 15.4% |
| 净利率 | 20.2% | 12.3% |
| 营收同比 | 12120.2% | 22.1% |
| 净利润同比 | 138.7% | 40.6% |
| 每股收益（稀释后） | $0.28 | $1.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $30.9M | $385.4M | ||
| Q3 25 | $861.0K | $354.7M | ||
| Q2 25 | $836.0K | $339.5M | ||
| Q1 25 | $868.0K | $324.1M | ||
| Q4 24 | $253.0K | $315.5M | ||
| Q3 24 | $987.0K | $301.0M | ||
| Q2 24 | $778.0K | $299.4M | ||
| Q1 24 | $620.0K | $278.7M |
| Q4 25 | $6.2M | $47.3M | ||
| Q3 25 | $-20.8M | $45.9M | ||
| Q2 25 | $-19.4M | $45.3M | ||
| Q1 25 | $-18.8M | $39.2M | ||
| Q4 24 | $-16.2M | $33.7M | ||
| Q3 24 | $-15.4M | $29.5M | ||
| Q2 24 | $-16.0M | $-60.2M | ||
| Q1 24 | $-13.5M | $11.0M |
| Q4 25 | 99.8% | 68.0% | ||
| Q3 25 | 94.3% | 67.8% | ||
| Q2 25 | 94.5% | 66.0% | ||
| Q1 25 | 94.9% | 66.6% | ||
| Q4 24 | 77.1% | 66.8% | ||
| Q3 24 | 93.1% | 66.5% | ||
| Q2 24 | 94.3% | 54.4% | ||
| Q1 24 | 94.5% | 65.0% |
| Q4 25 | 21.8% | 15.4% | ||
| Q3 25 | -2359.2% | 13.8% | ||
| Q2 25 | -2311.8% | 12.0% | ||
| Q1 25 | -2179.8% | 12.4% | ||
| Q4 24 | -6591.7% | 13.6% | ||
| Q3 24 | -1655.7% | 11.7% | ||
| Q2 24 | -2167.0% | -27.0% | ||
| Q1 24 | -2326.3% | 4.3% |
| Q4 25 | 20.2% | 12.3% | ||
| Q3 25 | -2419.0% | 12.9% | ||
| Q2 25 | -2316.1% | 13.3% | ||
| Q1 25 | -2160.7% | 12.1% | ||
| Q4 24 | -6385.4% | 10.7% | ||
| Q3 24 | -1562.9% | 9.8% | ||
| Q2 24 | -2054.0% | -20.1% | ||
| Q1 24 | -2171.5% | 3.9% |
| Q4 25 | $0.28 | $1.20 | ||
| Q3 25 | $-0.40 | $1.17 | ||
| Q2 25 | $-0.50 | $1.15 | ||
| Q1 25 | $-0.49 | $1.00 | ||
| Q4 24 | $-0.42 | $0.88 | ||
| Q3 24 | $-0.41 | $0.75 | ||
| Q2 24 | $-0.45 | $-1.55 | ||
| Q1 24 | $-0.38 | $0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $106.5M | $186.9M |
| 总债务越低越好 | $15.0M | — |
| 股东权益账面价值 | $53.6M | $1.4B |
| 总资产 | $114.9M | $1.8B |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
| Q4 25 | $106.5M | $186.9M | ||
| Q3 25 | $95.8M | $321.0M | ||
| Q2 25 | $33.9M | $421.8M | ||
| Q1 25 | $49.9M | $376.1M | ||
| Q4 24 | $66.8M | $324.4M | ||
| Q3 24 | $66.9M | $280.5M | ||
| Q2 24 | $65.2M | $288.3M | ||
| Q1 24 | $75.0M | $223.1M |
| Q4 25 | $15.0M | — | ||
| Q3 25 | $15.0M | — | ||
| Q2 25 | $15.0M | — | ||
| Q1 25 | $15.0M | — | ||
| Q4 24 | $15.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $53.6M | $1.4B | ||
| Q3 25 | $43.7M | $1.4B | ||
| Q2 25 | $295.0K | $1.3B | ||
| Q1 25 | $16.9M | $1.2B | ||
| Q4 24 | $33.0M | $1.2B | ||
| Q3 24 | $46.2M | $1.1B | ||
| Q2 24 | $44.1M | $1.2B | ||
| Q1 24 | $57.2M | $1.2B |
| Q4 25 | $114.9M | $1.8B | ||
| Q3 25 | $104.8M | $1.7B | ||
| Q2 25 | $42.8M | $1.7B | ||
| Q1 25 | $59.1M | $1.6B | ||
| Q4 24 | $76.2M | $1.5B | ||
| Q3 24 | $75.3M | $1.5B | ||
| Q2 24 | $72.4M | $1.5B | ||
| Q1 24 | $82.6M | $1.6B |
| Q4 25 | 0.28× | — | ||
| Q3 25 | 0.34× | — | ||
| Q2 25 | 50.85× | — | ||
| Q1 25 | 0.89× | — | ||
| Q4 24 | 0.46× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.3M | $86.5M |
| 自由现金流经营现金流 - 资本支出 | $-2.3M | $68.0M |
| 自由现金流率自由现金流/营收 | -7.4% | 17.7% |
| 资本支出强度资本支出/营收 | 0.1% | 4.8% |
| 现金转化率经营现金流/净利润 | -0.36× | 1.83× |
| 过去12个月自由现金流最近4个季度 | $-49.5M | $174.9M |
8季度趋势，按日历期对齐
| Q4 25 | $-2.3M | $86.5M | ||
| Q3 25 | $-14.6M | $58.3M | ||
| Q2 25 | $-15.5M | $44.9M | ||
| Q1 25 | $-16.6M | $49.0M | ||
| Q4 24 | $-13.5M | $51.1M | ||
| Q3 24 | $-13.7M | $56.5M | ||
| Q2 24 | $-10.2M | $22.6M | ||
| Q1 24 | $-13.1M | $38.3M |
| Q4 25 | $-2.3M | $68.0M | ||
| Q3 25 | $-14.9M | $42.0M | ||
| Q2 25 | $-15.6M | $29.4M | ||
| Q1 25 | $-16.7M | $35.5M | ||
| Q4 24 | $-13.6M | $45.7M | ||
| Q3 24 | $-13.8M | $51.0M | ||
| Q2 24 | $-10.3M | $18.1M | ||
| Q1 24 | $-13.1M | $32.5M |
| Q4 25 | -7.4% | 17.7% | ||
| Q3 25 | -1725.9% | 11.8% | ||
| Q2 25 | -1861.4% | 8.7% | ||
| Q1 25 | -1927.2% | 11.0% | ||
| Q4 24 | -5392.9% | 14.5% | ||
| Q3 24 | -1394.9% | 16.9% | ||
| Q2 24 | -1325.6% | 6.0% | ||
| Q1 24 | -2116.5% | 11.7% |
| Q4 25 | 0.1% | 4.8% | ||
| Q3 25 | 36.0% | 4.6% | ||
| Q2 25 | 4.1% | 4.6% | ||
| Q1 25 | 12.9% | 4.2% | ||
| Q4 24 | 41.9% | 1.7% | ||
| Q3 24 | 6.9% | 1.8% | ||
| Q2 24 | 13.8% | 1.5% | ||
| Q1 24 | 1.3% | 2.1% |
| Q4 25 | -0.36× | 1.83× | ||
| Q3 25 | — | 1.27× | ||
| Q2 25 | — | 0.99× | ||
| Q1 25 | — | 1.25× | ||
| Q4 24 | — | 1.52× | ||
| Q3 24 | — | 1.91× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
